↓ Skip to main content

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Overview of attention for article published in New England Journal of Medicine, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
51 news outlets
blogs
2 blogs
policy
1 policy source
twitter
132 X users
patent
1 patent
facebook
2 Facebook pages
reddit
4 Redditors
guideline
8 clinical guideline sources
podcasts
2 podcasts

Readers on

mendeley
626 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 132 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 626 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 626 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 60 10%
Other 41 7%
Student > Postgraduate 37 6%
Student > Master 32 5%
Student > Bachelor 30 5%
Other 76 12%
Unknown 350 56%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 155 25%
Biochemistry, Genetics and Molecular Biology 32 5%
Pharmacology, Toxicology and Pharmaceutical Science 19 3%
Agricultural and Biological Sciences 16 3%
Immunology and Microbiology 9 1%
Other 37 6%
Unknown 358 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 503. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2025.
All research outputs
#64,688
of 34,306,620 outputs
Outputs from New England Journal of Medicine
#1,967
of 38,325 outputs
Outputs of similar age
#1,681
of 466,853 outputs
Outputs of similar age from New England Journal of Medicine
#64
of 273 outputs
Altmetric has tracked 34,306,620 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,325 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 119.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.